EGR1 and Alzheimer disease: Together, TXNIP, EGR1, and IGFBP5 served as potential biomarkers for AD diagnosis reflecting different pathogenetic pathways involved in the development of AD, which may be due to the complicated and multiple pathophysiological manifestations of AD.